Karyopharm Therapeutics
KPTI
$1.10
Share price
3.77%
Change (1 day)
-71.43%
Change (1 year)
Categories
Earnings for Karyopharm Therapeutics (KPTI)
Earnings in 2023 (TTM): -$0.12 B
According to Karyopharm Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.12 B. In 2022 the company made an earning of -$0.14 B a decrease over its 2021 earnings that were of -$97.78 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Karyopharm Therapeutics from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.12 B | -14.99% |
| 2022 | -$0.14 B | 43.11% |
| 2021 | -$97.78 M | -42.09% |
| 2020 | -$0.17 B | -8.07% |
| 2019 | -$0.19 B | 5.76% |
| 2018 | -$0.18 B | 33.02% |
| 2017 | -$0.14 B | 19.28% |
| 2016 | -$0.11 B | -7.4% |
| 2015 | -$0.12 B | 55.96% |
| 2014 | -$75.78 M | 123.21% |
| 2013 | -$33.95 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $6.66 B | -5,702.21% | 🇺🇸 USA |
 Merck MRK | $3.03 B | -2,651.43% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | -$5.85 B | 4,814.55% | 🇺🇸 USA |
 Exelixis EXEL | $0.25 B | -316.49% | 🇺🇸 USA |